Hexagon Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Hexagon Capital Partners's GILD Position: Q1 2026 in Review
Hexagon Capital Partners opened a new position in Gilead Sciences (GILD) in Q1 2026: 6,747 shares worth $940K. The stake represents 0.14% of the portfolio and ranks #69 among its holdings. This is a return to the name: Hexagon Capital Partners previously reported a position in GILD as recently as Q1 2025.
Hexagon Capital Partners first reported a position in GILD in Q3 2020 and has held it in 20 quarters since. The position peaked at $992K in Q1 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Hexagon Capital Partners held 6,747 shares of Gilead Sciences worth $940K as of Q1 2026.
- Gilead Sciences was a new Hexagon Capital Partners position in Q1 2026.
- Gilead Sciences made up 0.14% of Hexagon Capital Partners's portfolio in Q1 2026, its #69 holding.
- Hexagon Capital Partners first reported a position in Gilead Sciences in Q3 2020 and has held it in 20 quarters since.
- Hexagon Capital Partners's Gilead Sciences position peaked at $992K in Q1 2025.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Hexagon Capital Partners's 13F filing for Q1 2026, filed 5 May 2026.